Marijuana and Medicine Assessing the Science Base 0309071550.pdf

(11525 KB) Pobierz
Marijuana and Medicine : Assessing the Science Base
98280772.001.png
PREFACE
i
Marijuana
and Medi c ine
Assessing the Science Base
Janet E. Joy, Stanley J. Watson, Jr., and
John A. Benson, Jr., Editors
Division of Neuroscience and Behavioral Health
INSTITUTE OF MEDICINE
NATIONAL ACADEMY PRESS
Washington, D.C.
 
NATIONAL ACADEMY PRESS • 2101 Constitution Avenue, N.W. • Washington, D.C. 20418
NOTICE: The project that is the subject of this report was approved by the Governing Board
of the National Research Council, whose members are drawn from the councils of the Na-
tional Academy of Sciences, the National Academy of Engineering, and the Institute of Medi-
cine. The principal investigators responsible for the report were chosen for their special
competences and with regard for appropriate balance.
The Institute of Medicine was chartered in 1970 by the National Academy of Sciences
to enlist distinguished members of the appropriate professions in the examination of policy
matters pertaining to the health of the public. In this, the Institute acts under both the
Academy’s 1863 congressional charter responsibility to be an adviser to the federal govern-
ment and its own initiative in identifying issues of medical care, research, and education. Dr.
Kenneth I. Shine is president of the Institute of Medicine.
This study was supported under Contract No. DC7C02 from the Executive Office of the
President, Office of National Drug Control Policy.
Library of Congress Cataloging-in-Publication Data
Marijuana and medicine : assessing the science base / Janet E. Joy,
Stanley J. Watson, Jr., and John A. Benson, Jr., editors ; Division
of Neuroscience and Behavioral Health, Institute of Medicine.
p. cm.
Includes bibliographical references and index.
ISBN 0-309-07155-0 (hardcover)
1. Marijuana—Therapeutic use. 2. Cannabinoids—Therapeutic use.
I. Joy, Janet E. (Janet Elizabeth), 1953- II. Watson, Stanley J.,
1943- III. Benson, John A. IV. Institute of Medicine (U.S.).
Division of Neuroscience and Behavioral Health.
RM666.C266 M365 1999
615
Additional copies of this report are available for sale from the National Academy Press,
2101 Constitution Avenue, N.W., Lock Box 285, Washington, D.C. 20055. Call (800) 624-6242
or (202) 334-3313 (in the Washington metropolitan area), or visit the NAP’s online bookstore
at www.nap.edu.
The full text of this report is available online at www.nap.edu.
For more information about the Institute of Medicine, visit the IOM home page at:
www4.nas.edu/IOM/.
Copyright 1999 by the National Academy of Sciences. All rights reserved.
Printed in the United States of America
Cover: Illustration from Marijuana Botany by Robert Connell Clarke, Ronin Publishing, 1981.
The serpent has been a symbol of long life, healing, and knowledge among almost all
cultures and religions since the beginning of recorded history. The image adopted as a logo-
type by the Institute of Medicine is based on a relief carving from ancient Greece, now held
by the Staatliche Museen in Berlin.
.32345—dc21
99-6484
PRINCIPAL INVESTIGATORS AND ADVISORY PANEL
JOHN A. BENSON, JR. ( Co-Principal Investigator ) , Dean and Professor
of Medicine, Emeritus, Oregon Health Sciences University School of
Medicine
STANLEY J. WATSON, JR. (C o-Principal Investigator ) , Co-Director and
Research Scientist, Mental Health Research Institute, University of
Michigan
STEVEN R. CHILDERS, Professor of Physiology and Pharmacology,
Center for Neuroscience, Bowman Gray School of Medicine, Wake
Forest University
J. RICHARD CROUT, President of Crout Consulting, Drug
Development and Regulation, Bethesda, Maryland
THOMAS J. CROWLEY, Professor, Department of Psychiatry, and
Executive Director, Addiction Research and Treatment Services,
University of Colorado Health Sciences Center
JUDITH FEINBERG, Professor, Department of Internal Medicine, and
Associate Director, Division of Infectious Diseases, University of
Cincinnati School of Medicine
HOWARD L. FIELDS, Professor of Neurology and Physiology,
University of California at San Francisco
DOROTHY HATSUKAMI, Professor of Psychiatry, University of
Minnesota
ERIC B. LARSON, Medical Director, University of Washington Medical
Center, and Associate Dean for Clinical Affairs, University of
Washington
BILLY R. MARTIN, Professor of Pharmacology and Toxicology, and
Director of National Institute on Drug Abuse Center on Drug
Abuse, Medical College of Virginia, Virginia Commonwealth
University
TIMOTHY L. VOLLMER, Professor of Medicine, Multiple Sclerosis
Research Center, Yale University School of Medicine
Study Staff
JANET E. JOY, Study Director
DEBORAH O. YARNELL, Research Associate
AMELIA B. MATHIS, Project Assistant
CHERYL MITCHELL, Administrative Assistant (until September 1998)
THOMAS J. WETTERHAN, Research Assistant (until September 1998)
CONSTANCE M. PECHURA, Division Director (until April 1998)
NORMAN GROSSBLATT, Manuscript Editor
iii
Consultant
MIRIAM DAVIS
Section Staff
CHARLES H. EVANS, JR., Head, Health Sciences Section
LINDA DEPUGH, Administrative Assistant
CARLOS GABRIEL, Financial Associate
iv
Zgłoś jeśli naruszono regulamin